Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,596
Total Claims
$1.6M
Drug Cost
778
Beneficiaries
$2,113
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-73%
Opioid rate vs peers
0.7% vs 2.6% avg
+98%
Cost per patient vs peers
$2,113 vs $1,068 avg
+29%
Brand preference vs peers
11.6% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.7%
Opioid Rate
144
Opioid Claims
$763
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,376 claims · $1.2M
Generic: 18,026 claims · $465K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 100 | $160K |
| Sitagliptin Phosphate | 113 | $142K |
| Dapagliflozin Propanediol | 83 | $102K |
| Levothyroxine Sodium | 834 | $89K |
| Apixaban | 103 | $78K |
| Rivaroxaban | 67 | $64K |
| Insulin Glargine,hum.Rec.Anlog | 80 | $58K |
| Candesartan/Hydrochlorothiazid | 199 | $43K |
| Insulin Nph Human Isophane | 90 | $40K |
| Sitagliptin Phos/Metformin Hcl | 39 | $39K |
| Sitagliptin Phos/Metformin Hcl | 31 | $35K |
| Linaclotide | 52 | $35K |
| Budesonide/Formoterol Fumarate | 53 | $32K |
| Insulin Glargine,hum.Rec.Anlog | 33 | $28K |
| Candesartan Cilexetil | 127 | $21K |
Prescribing Profile
Patient Profile
68
Avg Age
54%
Female
1.86
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data